PAPER Hartman VN, Miller MA, Clayton DF, Liu WC, Kroodsma DE, Brenowitz EA
SEARCH RESULTS
349869 RESULTS
PAPER Arai T, Ikeda K, Akiyama H, Tsuchiya K, Yagishita S, Takamatsu J
Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy.
Neuroreport. 2001 Apr 17;12(5):935-8. PubMed.PAPER Ueno M, Sakamoto H, Kanenishi K, Onodera M, Akiguchi I, Hosokawa M
Ultrastructural and permeability features of microvessels in the periventricular area of senescence-accelerated mice (SAM).
Microsc Res Tech. 2001 May 1;53(3):232-8. PubMed.PAPER Calero M, Pawlik M, Soto C, Castaño EM, Sigurdsson EM, Kumar A, Gallo G, Frangione B, Levy E
Distinct properties of wild-type and the amyloidogenic human cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type.
J Neurochem. 2001 Apr;77(2):628-37. PubMed.PAPER German DC, Quintero EM, Liang CL, Ng B, Punia S, Xie C, Dietschy JM
Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease.
J Comp Neurol. 2001 May 7;433(3):415-25. PubMed.PAPER Martin LJ, Kaiser A, Yu JW, Natale JE, Al-Abdulla NA
Injury-induced apoptosis of neurons in adult brain is mediated by p53-dependent and p53-independent pathways and requires Bax.
J Comp Neurol. 2001 May 7;433(3):299-311. PubMed.PAPER Tapiola T, Soininen H, Pirttilä T
CSF tau and Abeta42 levels in patients with Down's syndrome.
Neurology. 2001 Apr 10;56(7):979-80. PubMed.PAPER Lee FJ, Liu F, Pristupa ZB, Niznik HB
Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.
FASEB J. 2001 Apr;15(6):916-26. PubMed.PAPER Kitamura Y, Ishida Y, Takata K, Kakimura J, Mizutani H, Shimohama S, Akaike A, Taniguchi T
Alpha-synuclein protein is not scavenged in neuronal loss induced by kainic acid or focal ischemia.
Brain Res. 2001 Apr 13;898(1):181-5. PubMed.PAPER Tønder JE, Olesen PH
Agonists at the alpha4beta2 nicotinic acetylcholine receptors: structure-activity relationships and molecular modelling.
Curr Med Chem. 2001 May;8(6):651-74. PubMed.PAPER Culmsee C, Zhu X, Yu QS, Chan SL, Camandola S, Guo Z, Greig NH, Mattson MP
A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.
J Neurochem. 2001 Apr;77(1):220-8. PubMed.PAPER Liu B, Wang K, Gao HM, Mandavilli B, Wang JY, Hong JS
Molecular consequences of activated microglia in the brain: overactivation induces apoptosis.
J Neurochem. 2001 Apr;77(1):182-9. PubMed.PAPER Mukherjee P, Pasinetti GM
Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3.
J Neurochem. 2001 Apr;77(1):43-9. PubMed.PAPER Tagalakis AD, Graham IR, Riddell DR, Dickson JG, Owen JS
Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty.
J Biol Chem. 2001 Apr 20;276(16):13226-30. PubMed.PAPER Connell JW, Gibb GM, Betts JC, Blackstock WP, Gallo J, Lovestone S, Hutton M, Anderton BH
Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes.
FEBS Lett. 2001 Mar 23;493(1):40-4. PubMed.Current Filters
No filters selected